A recent study published in the Journal of the American College of Cardiology found that high plasma lipoproteins can cause ...

Scientists uncover hidden warning signs that predict heart attacks 30 years in advance, giving doctors a chance to stop them ...

New research reveals compelling evidence that hormone replacement therapy may offer significant cardiovascular benefits for ...

China: A study involving more than 17,000 adults with hypertension identified a U-shaped relationship between the ...

Deadly grip of cardiovascular diseases on Filipino families Second part: Breaking hearts and the bank: The cost of heart ...

Higher LDL cholesterol levels (≥130 mg/dL) were linked to longer survival in Sardinian nonagenarians, challenging the ...

Lp(a) is a lipoprotein that travels through the blood. Elevated levels of Lp(a) collect in the arteries, gradually narrowing them and limiting blood supply to the heart, brain, kidneys and legs.

Initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9 expected in the second quarter of 2025, ...

SLN ("Silence" or "the Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a ... drug reduced Lp(a) levels compared to placebo at all four doses tested, with ...

If your risk is low, you likely won't need a statin unless your levels of bad cholesterol exceed 190 mg/dL (4.92 mmol/L).

Cholesterol is a fatty substance found in blood and cells. It's crucial for the body's normal functioning, but having an ...